Awareness of adverse drug reactions reporting among doctors in a tertiary care centre

Authors

  • Laila K. V. Department of Pharmacology, Calicut Medical College, Kozhikode, Kerala, India
  • Hemalatha T. Department of Pharmacology, Calicut Medical College, Kozhikode, Kerala, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20163267

Keywords:

ADR, Pharmacovigilance, Awareness

Abstract

Background: Adverse drug reactions (ADR) are more commonly observed during treatment course in a substantial number of patients. Though we have a functioning pharmacovigilance programme in India, we have only fewer number of adverse drug reactions being reported indicating lack of awareness, the unsure attitude and reluctance in reporting adverse drug reactions.

Methods: We conducted a cross sectional pretested questionnaire based study for a period of six months. 600 questionnaires were distributed. 521 responded back to the questionnaire of which 29.6% were interns, 56.8% were junior residents, 5.2% doctors were senior residents, and 8.4% were Assistant professors. Awareness on ADR reporting, ADRs encountered in practice, common causative drugs for ADR, and awareness on the functions of Pharmacovigilance programme of India were assessed.

Results: 44.9% were not aware of the pharmacovigilance programme; 59.5% of the study population were not aware of the voluntary reporting of ADRs. 100% of the doctors who participated actively in the study responded that have not reported any ADR so far under pharmacovigilance programme of India. 88.1% of the doctors who participated in the study were willing to undergo a training on ADR reporting and pharmacovigilance.

Conclusions: This study concludes that serious measures have to be taken to educate the doctors on ADR reporting and pharmacovigilance. By means of involving pharmacovigilance as a part of the undergraduate programme and by organising regular workshops, group discussion and continuous medical education, we can improve the awareness among doctors regarding ADR reporting and pharmacovigilance.

References

Wu W, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. American Journal of Health-System Pharmacy. 2003;60(3):253-9.

WHO. International Drug Monitoring: The Role of the Hospital. Geneva, Switzerland: WHO; Technical Report Series No 425; 1966.

Haile DB, Ayen WY, Tiwari P. Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India. Ethiop J Health Sci. 2013;23(1):39-48.

The World Health Organization. Safety of Medicines: A guide for detecting and reporting adverse drug reactions. Geneva; WHO / EDM / QSM; 2002:2.

Prakash S. Pharmacovigilance in India. Indian J Pharmacol. 2007;39:123.

Van Grootheest K, de Jong-van D. Patients’ role in reporting adverse drug reactions. Expert Opin Drug Saf. 2004;3(4):363-8.

Van Grootheest K, Olsson S, Couper M. Pharmacists role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13(7):457-64.

Bisht M, Singh S, Dhasmana DC. Effect of educational intervention on adverse drug reporting by physicians: a cross-sectional study. Hindawi Publishing Corporation ISRN Pharmacology. 2014:8:Article ID 259476.

Abubakar AR, Simbak NB, Haque M. A systematic review of knowledge, attitude and practice on adverse drug reactions and pharmacovigilance among doctors. J App Pharm Sci. 2014;4(11):117-27.

Gupta SK. Post marketing surveillance. Text book of Pharmacovigilance, First edition, Jaypee Brothers Medical Publishers (P) Ltd. 2011;75.

Gupta YK. Ensuring patient safety-launching the new pharmacovigilance programme of India. Pharma Times. 2010;42(8):21-6.

Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: the knowledge, attitude and the practices of the medical students and the prescribers. Natl Med J India. 2002;15(1):24-6.

Desai, Iyer G, Panchal J, Shah S, Dikshit RK. An evaluation of the knowledge, attitude and the practice of adverse drug reaction reporting among the prescribers at a tertiary care hospital. Perspective in Clinical Research. 2011;2(4):129-35.

Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: knowledge, attitudes and perceptions among the resident doctors. J Pharm Sci Res. 2011;3:1064-9.

Vora MB. Knowledge on the adverse drug reactions and the pharmacovigilance activity among the undergraduate medical students of Gujarat. IJPSR. 2012;3(5):1511-5.

Downloads

Published

2017-01-10

How to Cite

V., L. K., & T., H. (2017). Awareness of adverse drug reactions reporting among doctors in a tertiary care centre. International Journal of Basic & Clinical Pharmacology, 5(5), 2236–2239. https://doi.org/10.18203/2319-2003.ijbcp20163267

Issue

Section

Original Research Articles